Supplementary figures S1-S9 from Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression
Liang Shi, Chawnshang Chang(China Medical University), Renan Jin, Shuyuan Yeh(University of Rochester Medical Center), Xiujun Cai(National Instruments (Ireland)), Junjie Xu(National Instruments (Ireland)), Hui Lin(Northwestern University), Yin Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Wen‐Lung Ma(Asia University), Gonghui Li(Sir Run Run Shaw Hospital)
Cited by 0
Related Papers
Induction of the TRPM-2 gene in cells undergoing programmed death.
|Molecular and Cellular Biology|1989|463
Androgen Receptor Is a New Potential Therapeutic Target for the Treatment of Hepatocellular Carcinoma
|Gastroenterology|2008|253
LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling
|Nature Communications|2019|223
Circular RNA expression is suppressed by androgen receptor (AR)-regulated adenosine deaminase that acts on RNA (ADAR1) in human hepatocellular carcinoma
|Cell Death and Disease|2017|220
ZnS@BSA Nanoclusters Potentiate Efficacy of Cancer Immunotherapy
|Advanced Materials|2021|218